Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
Not yet recruiting · NCT06641024 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 1 | 2024-10-15 | NCT06641024 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 34 |
| Ruijin Hospital | 454 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rui Jin hospital, Shanghai Jiao Tong university school of medicine | Shanghai | China | 1 |